Rapid Micro Biosystems, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Rapid Micro Biosystems, Inc. (RPID) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $3.91 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-08-07
- Rapid Micro Biosystems, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2026-03-31 was $4.20, a 20.00% increase year-over-year.
- Rapid Micro Biosystems, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2025-03-31 was $3.50, a 268.42% increase year-over-year.
- Rapid Micro Biosystems, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-03-31 was $0.95, a 23.39% decline year-over-year.
- Rapid Micro Biosystems, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-03-31 was $1.24, a 84.12% decline year-over-year.
- Rapid Micro Biosystems, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was $3.43, a 268.82% increase from fiscal 2024.
- Rapid Micro Biosystems, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $0.93, a 20.51% decline from fiscal 2023.
- Rapid Micro Biosystems, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $1.17, a 83.54% decline from fiscal 2022.
- Rapid Micro Biosystems, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $7.11, a 37.52% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.91 10-Q · filed 2026-08-07 | |||
| 2026-03-31 | $4.20 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | $3.43 10-K · filed 2026-03-12 | |||
| 2025-09-30 | $3.43 10-Q · filed 2025-11-07 | |||
| 2025-06-30 | $3.43 10-Q · filed 2025-08-12 | |||
| 2025-03-31 | $3.50 10-Q · filed 2025-05-09 | |||
| 2024-12-31 | $0.93 10-K · filed 2025-02-28 | |||
| 2024-09-30 | $0.93 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | $0.93 10-Q · filed 2024-08-02 | |||
| 2024-03-31 | $0.95 10-Q · filed 2024-05-03 | |||
| 2023-12-31 | $1.17 10-K · filed 2024-03-01 | |||
| 2023-09-30 | $1.17 10-Q · filed 2023-11-03 | |||
| 2023-06-30 | $1.18 10-Q · filed 2023-08-04 | |||
| 2023-03-31 | $1.24 10-Q · filed 2023-05-09 | |||
| 2022-12-31 | $7.11 10-K · filed 2023-03-10 | |||
| 2022-09-30 | $7.30 10-Q · filed 2022-11-10 | |||
| 2022-06-30 | $7.53 10-Q · filed 2022-08-12 | |||
| 2022-03-31 | $7.81 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | $11.38 10-K · filed 2022-03-24 | |||
| 2021-09-30 | $9.15 10-Q · filed 2021-11-15 | |||
| 2021-06-30 | $8.12 10-Q · filed 2021-08-27 |